tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ATHA Stock Latest News

Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
Press ReleasesAthira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
11d ago
ATHA
Athira Pharma appoints Javier San Martin as Chief Medical Officer
PremiumThe Fly
Athira Pharma appoints Javier San Martin as Chief Medical Officer
11d ago
ARWR
ATHA
Athira Pharma announces publication of preclinical data on fosgonimeton
PremiumThe Fly
Athira Pharma announces publication of preclinical data on fosgonimeton
15d ago
ATHA
Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease
PremiumPress Releases
Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease
15d ago
ATHA
Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting
PremiumPress Releases
Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting
23d ago
ATHA
Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International Conference
PremiumPress ReleasesAthira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International Conference
2M ago
ATHA
Athira Pharma presents clinical, preclinical data of fosgonimeton
PremiumThe Fly
Athira Pharma presents clinical, preclinical data of fosgonimeton
2M ago
ATHA
Athira Pharma Launches New Equity Incentive Plan for Talent
PremiumCompany Announcements
Athira Pharma Launches New Equity Incentive Plan for Talent
2M ago
8K
ATHA
Athira Pharma reports FY23 EPS ($3.09), consensus ($3.33)
PremiumThe Fly
Athira Pharma reports FY23 EPS ($3.09), consensus ($3.33)
2M ago
ATHA
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
PremiumPress Releases
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
2M ago
ATHA
2 “Strong Buy” Penny Stocks That Could Rally All the Way to $10 (or More)
PremiumStock Analysis & Ideas
2 “Strong Buy” Penny Stocks That Could Rally All the Way to $10 (or More)
2M ago
VOR
ATHA
Athira Pharma publishes research highlighting ATH-1105
PremiumThe Fly
Athira Pharma publishes research highlighting ATH-1105
3M ago
ATHA
Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)
PremiumPress ReleasesAthira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)
3M ago
ATHA
Fly Insider: Athira Pharma, Microstrategy among week’s notable insider trades
PremiumThe Fly
Fly Insider: Athira Pharma, Microstrategy among week’s notable insider trades
4M ago
ABNB
ATHA
Athira Pharma provides 2024 clinical pipeline outlook
PremiumThe Fly
Athira Pharma provides 2024 clinical pipeline outlook
4M ago
ATHA
Athira Pharma CMO Hans Moebius retires
PremiumThe Fly
Athira Pharma CMO Hans Moebius retires
4M ago
ATHA
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
PremiumPress Releases
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
4M ago
ATHA
Athira Pharma Completes Enrollment of Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease
PremiumPress Releases
Athira Pharma Completes Enrollment of Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease
4M ago
ATHA
Athira Pharma completes enrollment of Phase 2/3 LIFT-AD trial of fosgonimeton
PremiumThe Fly
Athira Pharma completes enrollment of Phase 2/3 LIFT-AD trial of fosgonimeton
4M ago
ATHA
Athira Pharma announces results from exploratory Phase 2 trial of fosgonimeton
PremiumThe FlyAthira Pharma announces results from exploratory Phase 2 trial of fosgonimeton
5M ago
ATHA
Athira Pharma Announces Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson’s Disease Dementia and Dementia with Lewy Bodies
PremiumPress Releases
Athira Pharma Announces Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson’s Disease Dementia and Dementia with Lewy Bodies
5M ago
ATHA
Athira Pharma to Participate in Sidoti December Small Cap Investor Conference
PremiumPress Releases
Athira Pharma to Participate in Sidoti December Small Cap Investor Conference
5M ago
ATHA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >